These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 6306043)
21. Different responses of growth hormone secretion to guanfacine, bromocriptine, and thyrotropin-releasing hormone in acromegalic patients with pure growth hormone (GH)-containing and mixed GH/prolactin-containing pituitary adenomas. Lamberts SW; Klijn JG; van Vroonhoven CC; Stefanko SZ J Clin Endocrinol Metab; 1985 Jun; 60(6):1148-53. PubMed ID: 3923021 [TBL] [Abstract][Full Text] [Related]
22. A comparison between the diagnostic value of gonadotropins, alpha-subunit, and chromogranin-A and their response to thyrotropin-releasing hormone in clinically nonfunctioning, alpha-subunit-secreting, and gonadotroph pituitary adenomas. Nobels FR; Kwekkeboom DJ; Coopmans W; Hoekstra R; De Herder WW; Bouillon R; Lamberts SW J Clin Endocrinol Metab; 1993 Sep; 77(3):784-9. PubMed ID: 7690365 [TBL] [Abstract][Full Text] [Related]
23. Thyrotropin-releasing hormone (TRH) binding sites and thyrotropin response to TRH are regulated by thyroid hormones in human thyrotropic adenomas. Le Dafniet M; Brandi AM; Kujas M; Chanson P; Peillon F Eur J Endocrinol; 1994 Jun; 130(6):559-64. PubMed ID: 8205254 [TBL] [Abstract][Full Text] [Related]
24. Evidence for tight coupling of receptor occupancy by thyrotropin-releasing hormone to phospholipase C-mediated phosphoinositide hydrolysis in rat pituitary cells: use of chlordiazepoxide as a competitive antagonist. Gershengorn MC; Paul ME Endocrinology; 1986 Aug; 119(2):833-9. PubMed ID: 3015558 [TBL] [Abstract][Full Text] [Related]
25. Presence of high affinity dopamine receptors in estrone-induced, prolactin-secreting rat pituitary adenomas: a model for human prolactinomas. Eljarmak D; Marchisio AM; Lis M; Collu R Horm Res; 1985; 21(2):107-16. PubMed ID: 3920132 [TBL] [Abstract][Full Text] [Related]
26. Receptors and neurohormones in human pituitary adenomas. Peillon F; Le Dafniet M; Garnier P; Brandi AM; Moyse E; Birman P; Blumberg-Tick J; Grouselle D; Joubert-Bression D Horm Res; 1989; 31(1-2):13-8. PubMed ID: 2566572 [TBL] [Abstract][Full Text] [Related]
27. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture. Ishibashi M; Yamaji T J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273 [TBL] [Abstract][Full Text] [Related]
28. Prolactin secretion after surgery or bromocriptine treatment of prolactinoma. De Leo V; Petraglia F; Sardelli S; Danero S; Genazzani AR; D'Antona N Obstet Gynecol; 1987 Jan; 69(1):99-103. PubMed ID: 3099236 [TBL] [Abstract][Full Text] [Related]
29. Morphological studies on mixed growth hormone (GH)- and prolactin (PRL)-secreting human pituitary adenomas. Coexistence of GH and PRL in the same secretory granule. Bassetti M; Spada A; Arosio M; Vallar L; Brina M; Giannattasio G J Clin Endocrinol Metab; 1986 Jun; 62(6):1093-100. PubMed ID: 3084531 [TBL] [Abstract][Full Text] [Related]
30. Structure of the thyrotrophin-releasing hormone receptor in human pituitary adenomas. Faccenda E; Melmed S; Bevan JS; Eidne KA Clin Endocrinol (Oxf); 1996 Mar; 44(3):341-7. PubMed ID: 8729534 [TBL] [Abstract][Full Text] [Related]
31. Evidence that signalling pathways by which thyrotropin-releasing hormone and gonadotropin-releasing hormone act are both common and distinct. Kaiser UB; Katzenellenbogen RA; Conn PM; Chin WW Mol Endocrinol; 1994 Aug; 8(8):1038-48. PubMed ID: 7527898 [TBL] [Abstract][Full Text] [Related]
32. The use of thyrotropin-releasing hormone in distinguishing prolactin-secreting pituitary adenoma. Marrs RP; Bertolli SJ; Kletzky OA Am J Obstet Gynecol; 1980 Nov; 138(6):620-5. PubMed ID: 6776812 [TBL] [Abstract][Full Text] [Related]
33. GH and PRL gene expression by nonradioisotopic in situ hybridization in TSH-secreting pituitary adenomas. Sanno N; Teramoto A; Matsuno A; Takekoshi S; Osamura RY J Clin Endocrinol Metab; 1995 Aug; 80(8):2518-22. PubMed ID: 7543115 [TBL] [Abstract][Full Text] [Related]
34. Normal and adenomatous human pituitaries secrete thyrotropin-releasing hormone in vitro: modulation by dopamine, haloperidol, and somatostatin. Le Dafniet M; Lefebvre P; Barret A; Mechain C; Feinstein MC; Brandi AM; Peillon F J Clin Endocrinol Metab; 1990 Aug; 71(2):480-6. PubMed ID: 1974264 [TBL] [Abstract][Full Text] [Related]
35. Diagnostic value of thyrotropin-releasing-hormone stimulation in patients with pituitary tumor. Cook DM; Greer MA; Paxton H West J Med; 1987 Aug; 147(2):161-4. PubMed ID: 3116772 [TBL] [Abstract][Full Text] [Related]
36. Human pituitary adenomas with hypersecretion of TSH and prolactin. Evidence that receptor sites for dopamin may be absent on TSH producing while present on prolactin producing cells. Werner S Horm Metab Res; 1979 Jul; 11(7):452-3. PubMed ID: 113330 [No Abstract] [Full Text] [Related]
38. The electrophysiological effects of thyrotropin-releasing hormone are similar in human TSH- and prolactin-secreting pituitary cells. Dufy B; Mollard P; Dufy-Barbe L; Manciet G; Guerin J; Roger P J Clin Endocrinol Metab; 1988 Dec; 67(6):1178-85. PubMed ID: 3142913 [TBL] [Abstract][Full Text] [Related]
39. Regulation of thyrotropin-releasing hormone receptors and responses by L-triiodothyronine in dispersed rat pituitary cell cultures. Hinkle PM; Goh KB Endocrinology; 1982 May; 110(5):1725-31. PubMed ID: 6280973 [TBL] [Abstract][Full Text] [Related]
40. Demonstration of specific dopamine receptors on human pituitary adenomas. Koga M; Nakao H; Arao M; Sato B; Noma K; Morimoto Y; Kishimoto S; Mori S; Uozumi T Acta Endocrinol (Copenh); 1987 Apr; 114(4):595-602. PubMed ID: 3577589 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]